Prevalence of COVID-19-like Symptoms among People Living with HIV, and Using Antiretroviral Therapy for Prevention and Treatment.
Adolescent
Adult
Aged
Anti-Retroviral Agents
/ therapeutic use
Betacoronavirus
COVID-19
Child
Comorbidity
Coronavirus Infections
/ epidemiology
Cross-Sectional Studies
Female
HIV Infections
/ drug therapy
Humans
Iran
/ epidemiology
Male
Middle Aged
Pandemics
/ statistics & numerical data
Pneumonia, Viral
/ epidemiology
Prevalence
SARS-CoV-2
Symptom Assessment
/ statistics & numerical data
Young Adult
COVID-19
HIV
SARS-CoV-2
antiretroviral treatment (ART)
coronavirus
pneumonia
Journal
Current HIV research
ISSN: 1873-4251
Titre abrégé: Curr HIV Res
Pays: Netherlands
ID NLM: 101156990
Informations de publication
Date de publication:
2020
2020
Historique:
received:
26
04
2020
revised:
16
06
2020
accepted:
24
06
2020
pubmed:
13
7
2020
medline:
29
10
2020
entrez:
13
7
2020
Statut:
ppublish
Résumé
COVID-19 has spread globally with remarkable speed, and currently, there is limited data available exploring any aspect of the intersection between HIV and SARSCoV- 2 co-infection. To estimate the prevalence of clinical symptoms associated with COVID-19 among people living with HIV (PLWH) in Tehran, Iran. Cross-sectional study. A total of 200 PLWH were recruited through the positive club via sampling, and completed the symptom-based questionnaire for COVID-19, which was delivered by trained peers. Of 200 participants, respiratory symptoms, including cough, sputum, and shortness of breath, were the most prevalent among participants, but only one person developed symptoms collectively suggested COVID-19 and sought treatments. It appears that existing infection with HIV or receiving antiretroviral treatment (ART) might reduce the susceptibility to the infection with SARS-CoV-2 or decrease the severity of the infection acquired. Further research is needed to understand causal mechanisms.
Sections du résumé
BACKGROUND
COVID-19 has spread globally with remarkable speed, and currently, there is limited data available exploring any aspect of the intersection between HIV and SARSCoV- 2 co-infection.
OBJECTIVE
To estimate the prevalence of clinical symptoms associated with COVID-19 among people living with HIV (PLWH) in Tehran, Iran.
DESIGN
Cross-sectional study.
METHODS
A total of 200 PLWH were recruited through the positive club via sampling, and completed the symptom-based questionnaire for COVID-19, which was delivered by trained peers.
RESULTS
Of 200 participants, respiratory symptoms, including cough, sputum, and shortness of breath, were the most prevalent among participants, but only one person developed symptoms collectively suggested COVID-19 and sought treatments.
CONCLUSION
It appears that existing infection with HIV or receiving antiretroviral treatment (ART) might reduce the susceptibility to the infection with SARS-CoV-2 or decrease the severity of the infection acquired. Further research is needed to understand causal mechanisms.
Identifiants
pubmed: 32652912
pii: CHR-EPUB-108102
doi: 10.2174/1570162X18666200712175535
doi:
Substances chimiques
Anti-Retroviral Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
373-380Subventions
Organisme : Tehran University of Medical Sciences
ID : 99-1-101-47301
Pays : International
Informations de copyright
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.